![Jordi Mata-Fink](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jordi Mata-Fink
Director Ejecutivo en Gate Bioscience, Inc. .
Cargos activos de Jordi Mata-Fink
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Analista de Capital Privado | 01/01/2013 | - |
Gate Bioscience, Inc.
![]() Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Director Ejecutivo | 01/01/2021 | - |
Fundador | 01/01/2021 | - |
Historial de carrera de Jordi Mata-Fink
Antiguos cargos conocidos de Jordi Mata-Fink.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Fundador | 01/01/2017 | - |
RUBIUS THERAPEUTICS | Director Técnico/Científico/I+D | 01/01/2014 | - |
Fundador | 01/01/2014 | - |
Formación de Jordi Mata-Fink.
Stanford University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Founder | 3 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
![]() Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
![]() Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
- Bolsa de valores
- Insiders
- Jordi Mata-Fink
- Experiencia